ATX-304
Tier C — Watch / tradeATX-304
Targets：PRKAB1, PCSK9
Indications (approved)：Type 2 diabetes, 线粒体疾病, Peripheral arterial disease
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| O-304-001 | 65608-74-4 | 1-(4-chlorobenzyl)urea |
| O-304-002 | 16794-67-5 | 4-chlorobenzoyl isothiocyanate |
| O-304-003 | - | 4-chloro-N-(((4-chlorobenzyl)carbamoyl)carbamothioyl)benzamide |
Frequently asked questions
What are the approved indications of ATX-304?
Approved indications include: Type 2 diabetes, 线粒体疾病, Peripheral arterial disease.
When does the ATX-304 patent expire?
No public expiry year is available for ATX-304 yet; this page updates once verified.
How many synthesis routes are recorded for ATX-304?
1 synthesis routes are recorded; the shortest is 2 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy ATX-304 intermediates?
All intermediates in ATX-304 routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for ATX-304 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-02